Operating Margin of C4 Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
C4 Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • C4 Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -431%, a 22% decline year-over-year.
  • C4 Therapeutics, Inc. annual Operating Margin for 2024 was -336%, a 50% increase from 2023.
  • C4 Therapeutics, Inc. annual Operating Margin for 2023 was -670%, a 61% decline from 2022.
  • C4 Therapeutics, Inc. annual Operating Margin for 2022 was -417%, a 132% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

C4 Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -431% -77% -22% 01 Jul 2025 30 Sep 2025
Q2 2025 -361% +44% +11% 01 Apr 2025 30 Jun 2025
Q1 2025 -293% +381% +57% 01 Jan 2025 31 Mar 2025
Q4 2024 -336% +334% +50% 01 Oct 2024 31 Dec 2024
Q3 2024 -354% +333% +48% 01 Jul 2024 30 Sep 2024
Q2 2024 -405% +497% +55% 01 Apr 2024 30 Jun 2024
Q1 2024 -674% -180% -36% 01 Jan 2024 31 Mar 2024
Q4 2023 -670% -253% -61% 01 Oct 2023 31 Dec 2023
Q3 2023 -687% 01 Jul 2023 30 Sep 2023
Q2 2023 -902% 01 Apr 2023 30 Jun 2023
Q1 2023 -494% 01 Jan 2023 31 Mar 2023
Q4 2022 -417% 01 Oct 2022 31 Dec 2022

C4 Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -336% +334% +50% 01 Jan 2024 31 Dec 2024
2023 -670% -253% -61% 01 Jan 2023 31 Dec 2023
2022 -417% -237% -132% 01 Jan 2022 31 Dec 2022
2021 -179% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.